All Modalities
TherapeuticsEarly Stage
Microbiome Therapeutics
Therapies that modulate the human microbiome to treat disease. Includes live biotherapeutics, engineered bacteria, and microbiome-derived metabolites targeting conditions from C. diff infections to inflammatory bowel disease.
Key Companies
Ferring (Rebyota)Seres TherapeuticsVedanta BiosciencesFinch Therapeutics